| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/05/2010 | EP2181708A1 Use of Valproate for reducing CHOP levels, particularly in a mammal having SCI |
| 05/05/2010 | EP2181707A1 Combined use of an alpha-adrenergic receptor antagonist and an anti-muscarinic agent |
| 05/05/2010 | EP2181706A2 Florfenicol esters for treating bacterial infections |
| 05/05/2010 | EP2181705A1 Sustained-release formulation of gliclazide |
| 05/05/2010 | EP2181704A2 Drug delivery from rapid gelling polymer composition |
| 05/05/2010 | EP2181114A1 New drugs with anticholestatic activity |
| 05/05/2010 | EP2181112A1 Triazolopyridine compounds and their use as ask inhibitors |
| 05/05/2010 | EP2181111A1 Thiadiazinone derivatives |
| 05/05/2010 | EP2181110A2 Novel heteroaromatic derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors |
| 05/05/2010 | EP2181108A2 3-hetrocyclylidene-indolinone derivatives as inhibitors of specific cell cycle kinases |
| 05/05/2010 | EP2181105A1 N5-(2-ethoxyethyl)-n3-(2-pyridinyl)-3,5-piperidinedicarboxamide derivatives for use as renin inhibitors |
| 05/05/2010 | EP2181104A1 Zearalenone macrolide derivatives and uses of the same |
| 05/05/2010 | EP2181099A2 Crystalline forms of erlotinib hcl and formulations thereof |
| 05/05/2010 | EP2181092A1 1,3-dihydroisoindole derivatives |
| 05/05/2010 | EP2181091A2 Amido derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors |
| 05/05/2010 | EP2180899A2 Cytoplasmic malate dehydrogenase (mdh1) targeted treatment for neurodegenerative diseases |
| 05/05/2010 | EP2180894A1 Methods of activating irs-1 and akt |
| 05/05/2010 | EP2180893A2 Pharmaceutical compositions and methods for the treatment of cancer |
| 05/05/2010 | EP2180891A2 Combination preparation comprising inhibitor of hmg-coa reductase and aspirin and method for manufacturing the same |
| 05/05/2010 | EP2180890A1 Methods of inhibiting or suppressing cellular proliferation |
| 05/05/2010 | EP2180889A1 Extracts with liver-x-receptor modulators, compounds and their use especially in weight control |
| 05/05/2010 | EP2180887A2 Pharmaceutical preparations containing highly volatile silicones |
| 05/05/2010 | EP2180883A1 Pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof |
| 05/05/2010 | EP2180880A2 Micelle encapsulation of therapeutic agents |
| 05/05/2010 | EP2180879A1 Non-textile polymer compositions and methods |
| 05/05/2010 | EP2180844A2 Sublingual fentanyl spray |
| 05/05/2010 | EP2180788A1 Anti-inflammatory compounds and uses thereof |
| 05/05/2010 | EP2180787A1 Nitrated-fatty acids modulation of type ii diabetes |
| 05/05/2010 | EP2102204B1 New aminopyrrolo[1,2- a]indole et aminopyridazino[1,6-a]indole derivatives, method for preparing the same and pharmaceutical compositions containing the same |
| 05/05/2010 | EP1987001B1 1-phenethylpiperidine derivatives and their use as opioid receptor ligands |
| 05/05/2010 | EP1957452B1 Novel forms of [r-(r*,r*)]-2-(4-fluorophenyl)-b,b-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-hept anoic acid magnesium |
| 05/05/2010 | EP1948648B1 3-aryl-isoxazole-4-carbonyl-benzofurane derivatives |
| 05/05/2010 | EP1891001B1 SULFONAMIDE DERIVATIVES USEFUL AS LIVER CARNITINE PALMITOYL TRANSFERASE (L-CPTl) INHIBITORS |
| 05/05/2010 | EP1734987B1 Interferon-beta for anti-virus therapy for respiratory diseases |
| 05/05/2010 | EP1718290B1 Composition, comprising l-serine, l-isoleucine, folic acid and trace elements, for treating psoriasis |
| 05/05/2010 | EP1713468B1 Anthelmintic composition |
| 05/05/2010 | EP1691926B1 Phosphatase inhibitor sample collection system |
| 05/05/2010 | EP1615914B1 Cgrp receptor antagonists |
| 05/05/2010 | EP1572106B1 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis |
| 05/05/2010 | EP1569929B1 Compounds and methods for the treatment or prevention of flavivirus infections |
| 05/05/2010 | EP1485100B1 Azinylaminoazoles as inhibitors of protein kinases |
| 05/05/2010 | EP1485081B1 Ibuprofen solution for hard shell capsules |
| 05/05/2010 | EP1474147B1 Pyrimidine-based compounds useful as gsk-3 inhibitors |
| 05/05/2010 | EP1472240B1 Drechslera anole derivatives, method for the production and use thereof |
| 05/05/2010 | EP1436278B1 A process for the preparation of the 14beta-hydroxy-baccatin iii-1,14-carbonate |
| 05/05/2010 | EP1421058B1 Processes for the production of alpha-difluoromethyl ornithine (dfmo) |
| 05/05/2010 | EP1417206B1 Novel 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient |
| 05/05/2010 | EP1411993B1 Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy |
| 05/05/2010 | EP1390026B1 Treatment of hpv caused diseases |
| 05/05/2010 | EP1328504B1 Aliphatic amino-substituted demethoxylated hypocrellins and their synthesis |
| 05/05/2010 | EP1326847B1 (2s)-2-(adamantan-1-ylmethoxycarbonylamino)-3-(4-(2-(1,4,5,6-tetrahydropyrimidin-2-ylcarbamoyl)ethyl)benzoylamino)propionic acid isopropyl ester, its preparation and its use |
| 05/05/2010 | EP1274414B1 Nasal administration of metoclopramide for the treatment of gastroparesis |
| 05/05/2010 | EP1267894B1 Viscoelastics for use in middle ear surgery |
| 05/05/2010 | EP1232157B1 Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof |
| 05/05/2010 | EP1227803B1 compounds for inhibiting iapp-associated amyloid deposits |
| 05/05/2010 | EP1167366B1 Amine derivatives |
| 05/05/2010 | EP1166788B1 Remedies for joint diseases |
| 05/05/2010 | EP1162976B1 16-phenoxy-lipoxin analogs for medical use |
| 05/05/2010 | EP1115398B1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 05/05/2010 | EP1089969B1 Stable no-delivering compounds |
| 05/05/2010 | EP0946185B2 PHARMACEUTICAL COMPOSITION COMPRISING A COMPOUND HAVING ANTI-Xa ACTIVITY AND A PLATELET AGGREGATION ANTAGONIST COMPOUND |
| 05/05/2010 | CN1993132B Film coated tablet having plural coats |
| 05/05/2010 | CN1993120B Arylacetic acids and related compounds for treatment of alzheimer's disease |
| 05/05/2010 | CN1982327B Phytosterin compound and its use |
| 05/05/2010 | CN1981044B Lipid encapsulated interfering RNA |
| 05/05/2010 | CN1980949B New 2-substituted d-homo-estra-1,3,5(10)-trienes as inhibitors of 17beta-hydroxy steroid dehydrogenase type 1 |
| 05/05/2010 | CN1964729B Composition for prevention and treatment of urinary incontinence |
| 05/05/2010 | CN1964719B Use of loteprednol etabonate for the treatment of dry eye |
| 05/05/2010 | CN1954812B Use of Edaravone |
| 05/05/2010 | CN1953757B Composition for cleaning intestinal canal |
| 05/05/2010 | CN1947767B Medicine for treating and preventing infantile mental retardation, and its preparation method |
| 05/05/2010 | CN1939438B Chinese medicinal composition, its extract containing insect and its preparation |
| 05/05/2010 | CN1935157B Medical stone emulsifiable paste for treating skin disease and its preparing method |
| 05/05/2010 | CN1923282B Anti-cancer slow release injection comprising hormone drug |
| 05/05/2010 | CN1921867B Nucleoside phosphonate derivatives useful in the treatment of HIV infections |
| 05/05/2010 | CN1921829B Patch |
| 05/05/2010 | CN1911219B Medicine composition, and its application |
| 05/05/2010 | CN1910177B Substituted quinolines and their use as mycobacterial inhibitors |
| 05/05/2010 | CN1907987B Entecavir acid addition salt, preparation method and use thereof |
| 05/05/2010 | CN1903208B Adefovir dipivoxil oral disintegration tablets preparation method |
| 05/05/2010 | CN1891229B Medicinal composition for preventing or treating metabolic syndrome |
| 05/05/2010 | CN1889847B Package drink |
| 05/05/2010 | CN1883493B Solid-state molecular dispersible preparation of pennogenin compound |
| 05/05/2010 | CN1883443B A health buccal spray and method for preparing same |
| 05/05/2010 | CN1878767B Azole-based kinase inhibitors |
| 05/05/2010 | CN1875968B Application of anisodamine in preparation of smoking-stopping medicament |
| 05/05/2010 | CN1863779B Novel indazole derivative |
| 05/05/2010 | CN1861104B Inula flower extractive used to breat diabets mellitus and hyperlipidemia |
| 05/05/2010 | CN1832925B New P2X7 receptor avtagonists and their use |
| 05/05/2010 | CN1813740B Sublingual pellicles containing naloxone hydrochloride and preparing method thereof |
| 05/05/2010 | CN1809353B Medicine for prevention of and treatment for arteriosclerosis and hypertension. |
| 05/05/2010 | CN1807413B Carbazole sulfonamide derivative and its preparation method |
| 05/05/2010 | CN1806857B Multilayer-coated stent for controlled drug release and manufacturing method thereof |
| 05/05/2010 | CN1788730B Gel containing centella general glycoside and sodium hyaluronate for preparing drop and spray agent |
| 05/05/2010 | CN1787820B Composition for improving cognition and memory |
| 05/05/2010 | CN1774241B Oral drug delivery system comprising high viscosity liquid carrier materials |
| 05/05/2010 | CN1764661B Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain. |
| 05/05/2010 | CN1762390B Burn and boil medicine and its preparation method |
| 05/05/2010 | CN1761461B Application of prostaglandin composition for treatment of premature ejaculation |
| 05/05/2010 | CN1761450B Skin preparation for external use characterized by containing sugar derivative of a,a-trehalose |